Experimental cancer therapeutics delivered to tumors via nanoparticles could provide a safer and more effective therapy than conventional chemotherapy.
Experimental cancer therapeutics delivered to tumors via nanoparticles could provide a safer and more effective therapy than conventional chemotherapy.
Some notable quotes from this week’s meeting on cancer research
Researchers have genetically engineered a virus that is deadly to chickens and found that it can kill prostate cancer in vitro.
Physicist-turned-oncologist Robert Austin argues that cancer is a natural consequence of our rapid evolution.
Researchers are taking advantage of small, transparent zebrafish embryos and larvae—and a special strain of see-through adults—to understand the development and spread of cancer.
Every member of the scientific review panel at Texas’s $3-billion cancer research funding agency has quit, citing concerns about a lack of proper peer review.
A small patient trial offers hope that cancer-killing viruses might be a viable therapy after all.
Using RNA viruses to silence genes could optimize tissue targeting while reducing toxicity.
Page 1 of 1